hesperetin has been researched along with Disease Models, Animal in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 17 (70.83) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W | 1 |
| Baradaran, S; Ghasemi-Kasman, M; Moghaddam, AH | 1 |
| Bai, YF; Fan, XY; Sheng, H; Wang, SW; Wang, W; Weng, YY; Xu, ZC; Zhang, F; Zheng, F; Zhu, XT | 1 |
| Alizadeh Makvandi, A; Amiri Moghaddam, S; Khalili, M; Roghani, M | 1 |
| Hajizadeh Moghaddam, A; Kheradmand, E; Zare, M | 1 |
| Ding, HW; Huang, AL; Huang, C; Li, B; Li, J; Meng, XM; Zhang, YL | 1 |
| Kong, R; Lu, J; Luo, H; Wang, N | 1 |
| Baradaran, S; Ghasemi-Kasman, M; Hajizadeh Moghaddam, A | 1 |
| Chang, JH; Hong, J; Jeon, MT; Jung, UJ; Kim, DW; Kim, S; Kim, SR; Kwon, JY; Moon, GJ; Shin, M | 1 |
| Ali, T; Ikram, M; Jo, MG; Khan, A; Kim, MO; Muhammad, T; Rehman, SU | 1 |
| Kaufman, RJ; Li, H; Monks, TJ; O'Meara, M; Seyoum, B; Wang, JM; Yi, Z; Zhang, K; Zhang, X | 1 |
| Aswar, M; Aswar, U; Kute, P; Mahajan, S; Mahajan, U; Nerurkar, G | 1 |
| Iranshahi, M; Parhiz, H; Rezaee, R; Roohbakhsh, A; Soltani, F | 1 |
| Ansarin, K; Kolahian, S; Pour Moghaddam, M; Sakhinia, E; Sakhinia, M; Seyedrezazadeh, E; Shahbazfar, AA; Vafa, M | 1 |
| Bando, M; Nakazawa, Y; Oka, M; Takehana, M | 1 |
| Caldwell, RB; Kimura, S; Kobayashi, H; Matsumoto, C; Nagaoka, T; Narayanan, SP; Ono, S; Shimouchi, A; Takumi, H; Tamai, T; Yokota, H; Yoshida, A | 1 |
| Demirtaş, S; Dereköy, FS; Güçlü, O; Kara, M; Karaca, T; Türkön, H; Türkyılmaz, M; Uysal, S | 1 |
| Aranganathan, S; Nalini, N; Selvam, JP | 1 |
| Aranganathan, S; Nalini, N | 1 |
| Cho, YY; Choi, MS; Jeon, SM; Kim, HJ; Kwon, EY; Lee, JH; Lee, MK | 1 |
| Dube, V; Joseph, SK; Lakshmi, V; Mishra, SK; Murthy, PK; Sahoo, MK; Srivastava, S; Verma, SK | 1 |
| Pari, L; Shagirtha, K | 1 |
| Jena, GB; Kushwaha, S; Tripathi, DN; Trivedi, PP | 1 |
| de la Rocha, NE; Guardia, T; Juárez, AO; Pelzer, LE; Rotelli, AE | 1 |
2 review(s) available for hesperetin and Disease Models, Animal
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People | 2021 |
Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Citrus; Disease Models, Animal; Hesperidin; Humans; Inflammation; NF-kappa B; Oxidative Stress; Signal Transduction | 2015 |
22 other study(ies) available for hesperetin and Disease Models, Animal
| Article | Year |
|---|---|
Nano-hesperetin enhances the functional recovery and endogenous remyelination of the optic pathway in focal demyelination model.
Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Male; Optic Chiasm; Rats; Rats, Wistar; Recovery of Function; Remyelination; Visual Cortex; Visual Pathways | 2020 |
Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway.
Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Enzyme Activation; Galactosamine; HEK293 Cells; Hesperidin; Humans; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Protein Processing, Post-Translational; RAW 264.7 Cells; Signal Transduction; Sirtuin 1; Transcription Factor RelA | 2020 |
Hesperetin ameliorates electroconvulsive therapy-induced memory impairment through regulation of hippocampal BDNF and oxidative stress in a rat model of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Electroconvulsive Therapy; Hesperidin; Hippocampus; Male; Maze Learning; Memory Disorders; Oxidative Stress; Rats; Rats, Wistar; Reserpine | 2021 |
Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hesperidin; Hippocampus; Male; Malondialdehyde; Memory Disorders; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2018 |
Design, synthesis and investigation of potential anti-inflammatory activity of O-alkyl and O-benzyl hesperetin derivatives.
Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hesperidin; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred Strains; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; RAW 264.7 Cells; Signal Transduction; Structure-Activity Relationship | 2018 |
Hesperetin Mitigates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting Extracellular Matrix and Cell Apoptosis via the TGF-β1/Smad Pathway.
Topics: Animals; Apoptosis; Disease Models, Animal; Extracellular Matrix; Hesperidin; Interleukin-6; Liver Cirrhosis; Male; Mice; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2018 |
Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm.
Topics: Animals; Antioxidants; Citrus; Demyelinating Diseases; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Lysophosphatidylcholines; Male; Multiple Sclerosis; Myelin Sheath; Neuroglia; Optic Chiasm; Rats; Rats, Wistar | 2018 |
Beneficial Effects of Hesperetin in a Mouse Model of Temporal Lobe Epilepsy.
Topics: Administration, Oral; Animals; Anticonvulsants; Citrus; Disease Models, Animal; Epilepsy, Temporal Lobe; Fruit; Hesperidin; Kainic Acid; Male; Mice; Phytotherapy | 2018 |
Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; Biomarkers; Cell Line; Cognitive Dysfunction; Disease Models, Animal; Hesperidin; Hippocampus; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Neuroprotection; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Synapses; Toll-Like Receptor 4 | 2019 |
Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.
Topics: Animals; Bone Marrow Cells; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Endoribonucleases; Gene Knock-In Techniques; Gene Transfer Techniques; Hesperidin; Lactoylglutathione Lyase; Mice; Neovascularization, Physiologic; Protein Serine-Threonine Kinases; Pyruvaldehyde; Resveratrol; Skin; Stem Cells; Wound Healing; Wounds and Injuries | 2019 |
Protective effect of hesperetin in rat model of partial sciatic nerve ligation induced painful neuropathic pain: an evidence of anti-inflammatory and anti-oxidative activity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Female; Hesperidin; Male; Neuralgia; Rats; Rats, Wistar; RNA, Messenger; Sciatic Nerve; Tumor Necrosis Factor-alpha | 2014 |
Effects of the flavanone combination hesperetin-naringenin, and orange and grapefruit juices, on airway inflammation and remodeling in a murine asthma model.
Topics: Airway Remodeling; Animals; Asthma; Beverages; Bronchoalveolar Lavage Fluid; Citrus paradisi; Citrus sinensis; Disease Models, Animal; Eosinophils; Flavanones; Fruit; Hesperidin; Inflammation; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C | 2015 |
Hesperetin prevents selenite-induced cataract in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Cataract; Disease Models, Animal; Eye Proteins; Female; Free Radical Scavengers; Glutathione; Hesperidin; Intermediate Filament Proteins; Lens, Crystalline; Oxidative Stress; Proteolysis; Rats; Rats, Sprague-Dawley; Sodium Selenite | 2015 |
Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury.
Topics: Animals; Biomarkers; Blotting, Western; Disease Models, Animal; Hesperidin; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Interleukin-1beta; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; Solubility; Water | 2016 |
Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Proliferation; Cisplatin; Cochlea; Disease Models, Animal; Ear, Inner; Hearing Loss; Hesperidin; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Otoacoustic Emissions, Spontaneous; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Signal-To-Noise Ratio; Spiral Ganglion | 2016 |
Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study.
Topics: 1,2-Dimethylhydrazine; Animals; Bacteria; Body Weight; Carcinogens; Cell Transformation, Neoplastic; Citrus; Colon; Colonic Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Feces; Flavanones; Hesperidin; Injections, Subcutaneous; Intestinal Mucosa; Male; Phytotherapy; Precancerous Conditions; Rats; Rats, Wistar | 2008 |
Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Catalase; Colon; Colonic Neoplasms; Disease Models, Animal; Hesperidin; Lipid Peroxidation; Liver; Male; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Caffeic Acids; Cholesterol; Cholesterol, HDL; Coumaric Acids; Cricetinae; Disease Models, Animal; Hesperidin; Humans; Hypercholesterolemia; Male; Mesocricetus | 2010 |
Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi.
Topics: Animals; Brugia malayi; Coloring Agents; Disease Models, Animal; Elephantiasis, Filarial; Female; Filaricides; Flavanones; Flavonoids; Gerbillinae; Hesperidin; Humans; Male; Murinae; Rutin; Survival Analysis; Tetrazolium Salts; Thiazoles | 2010 |
Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats.
Topics: Animals; Antioxidants; Cadmium; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hesperidin; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar | 2012 |
Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Caspase 3; Comet Assay; Cytoprotection; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Heart Diseases; Hesperidin; In Situ Nick-End Labeling; Male; Malondialdehyde; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Comparative study of flavonoids in experimental models of inflammation.
Topics: Animals; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Ear; Edema; Flavonoids; Hesperidin; Hindlimb; Inflammation; Mice; Molecular Structure; Quercetin; Random Allocation; Rats; Rats, Wistar; Rutin; Xylenes | 2003 |